Zura Bio Limited
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | – | – | – | +444.4% | |
| – | – | +2,790.7% | +74.0% | -26.6% | |
| – | -49.1% | – | – | – | |
| – | – | +44.5% | -54.9% | -257.5% | |
| – | +299,999,900.0% | -33.3% | -99.1% | +50.7% | |
| – | -91.4% | -33.3% | -36.6% | -97.8% | |
| – | +0.0% | -220.6% | -100.0% | – | |
| – | -89.5% | +721.3% | -9.4% | -102.0% | |
| – | +114.9% | +6,169.2% | -21.9% | -187.5% | |
| – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.